Stereotaxis, Inc. (STXS): Capital Expenditures
$93.0K
Year ended 2025-12-31
$213.0K
Trailing 12 months to 2026-06-30
-66.1%
3-year compound annual growth
+5.6%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $93.0K | +173.5% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $34.0K | -90.7% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $366.0K | -84.6% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $2.38M | +70.2% | 2024-03-08, From 2022-01-01 |
| 2021-12-31 | $1.40M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $70.9K | +140.4% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $29.5K | -88.9% | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | $265.5K | +225.4% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $81.6K | -80.1% | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | $410.2K | n/a | 2018-03-20, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $93.0K | +173.5% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $66.0K | n/a |
| Precision Optics Corporation, Inc. (POCI) | 2026-06-30 | $426.8K | +87.8% |
| Iridex Corp (IRIX) | 2026-01-03 | $143.0K | +1000.0% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $124.0K | +40.9% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.25M | +377.9% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $1.19M | +209.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $90.0K | -41.2% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $4.4K | +13.9% |
Compare STXS, ECOR, POCI, IRIX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗